Owens & Minor, Inc. has finalized the divestiture of its Products & Healthcare Services segment and the Owens & Minor brand to Platinum Equity for $375 million in cash, subject to customary post-closing adjustments for cash, indebtedness, net working capital and transaction expenses. As part of the transaction, Owens & Minor retains a 5% equity stake in the divested business and preserves tax attributes in excess of $150 million. This deal represents the culmination of the definitive agreement announced on October 7 and allows the company to streamline its operations around home-based care services.

Following the sale, the publicly traded parent company will be renamed Accendra Health, Inc., reflecting its new identity as a nationwide pure-play home-based care platform. Edward A. Pesicka, President & Chief Executive Officer, emphasized that the company’s comprehensive product portfolio, extensive payer contracts and national footprint position Accendra Health to capitalize on the evolving home-based care market. The rebranding underscores a strategic shift from a diversified healthcare products provider to a focused service provider supporting patients with chronic conditions.

With full attention on its Apria and Byram brands, Accendra Health plans to allocate capital toward high-return investments in clinical services, technology integration and targeted geographic expansion. The company’s leadership expects cost-saving initiatives and operational efficiencies to drive improved margins, while preserving financial flexibility for selective acquisitions. Management has outlined a goal to achieve low-double-digit revenue growth and mid-teens adjusted EBITDA margins by fiscal 2025, supported by its payor mix and scalable service model.

This release includes forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from current expectations. Investors are directed to the company’s Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K, for a detailed discussion of risk factors, including macroeconomic fluctuations, reimbursement trends, integration challenges and regulatory changes. Accendra Health disclaims any obligation to update forward-looking statements except as required by law.